Analysis of circulating tumour DNA (ctDNA) from patients enrolled in the IDEA-FRANCE phase III trial: Prognostic and predictive value for adjuvant treatment duration
ANNALS OF ONCOLOGY Volume: 30 Supplement: 5 Pages: 867-867 Meeting Abstract: LBA30_PR Published: OCT 2019